| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Molecular Partners AG American Depositary Shares (NASDAQ: MOLN)
MOLN Technical Analysis
5
| As on 9th Jun 2023 MOLN STOCK Price closed @ 6.84 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 12.82 & Strong Sell for SHORT-TERM with Stoploss of 24.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MOLNSTOCK Price
| Open | 6.62 | Change | Price | % |
| High | 6.84 | 1 Day | -0.09 | -1.30 |
| Low | 6.62 | 1 Week | 0.31 | 4.75 |
| Close | 6.84 | 1 Month | 0.28 | 4.27 |
| Volume | 1264 | 1 Year | -11.66 | -63.03 |
| 52 Week High 31.89 | 52 Week Low 5.60 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MOLN Daily Charts |
MOLN Intraday Charts |
Whats New @ Bazaartrend |
MOLN Free Analysis |
|
|
MOLN Important Levels Intraday
| RESISTANCE | 7.26 |
| RESISTANCE | 7.13 |
| RESISTANCE | 7.04 |
| RESISTANCE | 6.96 |
| SUPPORT | 6.72 |
| SUPPORT | 6.64 |
| SUPPORT | 6.55 |
| SUPPORT | 6.42 |
MOLN Forecast May 2024
| 4th UP Forecast | 37.48 |
| 3rd UP Forecast | 27.65 |
| 2nd UP Forecast | 21.58 |
| 1st UP Forecast | 15.51 |
| 1st DOWN Forecast | -1.83 |
| 2nd DOWN Forecast | -7.9 |
| 3rd DOWN Forecast | -13.97 |
| 4th DOWN Forecast | -23.8 |
MOLN Weekly Forecast
| 4th UP Forecast | 11.43 |
| 3rd UP Forecast | 9.96 |
| 2nd UP Forecast | 9.05 |
| 1st UP Forecast | 8.14 |
| 1st DOWN Forecast | 5.54 |
| 2nd DOWN Forecast | 4.63 |
| 3rd DOWN Forecast | 3.72 |
| 4th DOWN Forecast | 2.25 |
MOLN Forecast2024
| 4th UP Forecast | 57.98 |
| 3rd UP Forecast | 41.58 |
| 2nd UP Forecast | 31.44 |
| 1st UP Forecast | 21.3 |
| 1st DOWN Forecast | -7.62 |
| 2nd DOWN Forecast | -17.76 |
| 3rd DOWN Forecast | -27.9 |
| 4th DOWN Forecast | -44.3 |
Molecular Partners AG American Depositary Shares ( NASDAQ USA Symbol : MOLN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MOLN Business Profile
Molecular Partners AG operates as a clinical-stage biopharmaceutical company. It is developing Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of wet age-related macular degeneration, as well as for diabetic macular edema; and MP0250 that binds and inhibit vascular endothelial growth factor and hepatocyte growth factor pathways, which restores clinical sensitivity to various standard-of-care therapies in multiple myeloma. The company is also developing MP0274 that is in Phase I clinical trials for HER2-positive solid tumors; MP0310, which is in Phase I clinical trials for immuno-oncology; MPO317, a tumor-localized immune agonist that activates immune cells in the tumor; and Peptide-MHC, a tumor-localized immune-cell agonist to attack tumors. It has strategic partnerships with Allergan, Inc. and Amgen SA; and collaboration with AGC Biologics to develop anti-COVID-19 DARPin program. Molecular Partners AG was founded in 2004 and is headquartered in Schlieren, Switzerland. Address: Wagistrasse 14, Schlieren, Switzerland, 8952
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service